Author: Danielle Keane, NORML Political Director

The Changing Nature of Marijuana Politics – and How You Can Help

As I finish my first month as a NORML staff member, I am in awe of the incredible group of individuals that comprise NORML’s network; I’m also in awe of the political momentum that we presently enjoy. NORML held a Legislative ‘Fly-In’/Lobby Day in Washington, DC just before I began my tenure here. Attendees visited with their US Senators and urged them to vote in favor of the Veterans Equal Access Amendment, permitting veterans the ability to utilize medical cannabis. The vote marked the first time the U.S. Senate had […]

NIDA Acknowledges Drawbacks to Monopoly on Marijuana Supply

Members of the US Senate at a hearing yesterday expressed skepticism in regard to federal policies limiting the ability of investigators to engage in clinical studies of marijuana’s health benefits. Senators heard from representatives from the Drug Enforcement Administration (DEA), Food and Drug Administration (FDA), National Institute on Drug Abuse (NIDA), University of Mississippi Medical Center, Arrowhead Regional Medical Center and Project SAM on a variety of issues The hearing’s most noteworthy moment came when Nora Volkow, director of NIDA, acknowledged that the monopoly on marijuana cultivation for research purposes […]